DJIA 17,619.51 23.16 0.13%
NASDAQ 4,986.87 28.40 0.57%
S&P 500 2,063.11 5.47 0.27%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)

2.08 -0.03 (-1.42%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ATRS $2.08 -1.42%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.11
Previous Close $2.11
Daily Range $2.06 - $2.17
52-Week Range $1.82 - $3.04
Market Cap $274.0M
P/E Ratio -8.44
Dividend (Yield) $0.00 (0.0%)
Volume 1,238,609
Average Daily Volume 939,424
Current FY EPS -$0.12

Sector

Healthcare

Industry

Healthcare IT

Antares Pharma, Inc. (ATRS) Description

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems. Website: http://www.antarespharma.com/

News & Commentary Rss Feed

Why Shares in Antares Pharma, Inc. Burst Today

Antares Pharma, Inc. shares tumbled after it priced its secondary stock offering.

InsiderInsights.com Daily Round Up 6/15/15: FGP, KMI, FMI, WPG

Earnings Estimates Moving Higher for Antares (ATRS): Time to Buy? - Tale of the Tape

A Letter To Antares Pharma's Board Of Directors

Sell These 7 Health Care Supplies Companies Now

Analyst Offers Top US Growth Stock Calls for This Week

Top Analyst Upgrades and Downgrades: Antares, Michael Kors, Palo Alto, Ralph Lauren, Chipotle, Erics

Top Analyst Upgrades and Downgrades: Antares, Michael Kors, Palo Alto, Ralph Lauren, Chipotle, Ericsson, and More

Health Care Sector Update for 05/28/2015: KPTI, ATRS, ZFGN

Benzinga's Top Initiations

Piper Jaffray Initiates Antares Pharma With Overweight

Antares Pharma's (ATRS) CEO Eamonn Hobbs on Q1 2015 Results - Earnings Call Transcript

See More ATRS News...

ATRS's Top Competitors

ATRS $2.08 (-1.42%)
Current stock: ATRS
$0.00 (0.00%)
Current stock:
MDT $74.10 (1.09%)
Current stock: MDT
COV $0.00 (0.00%)
Current stock: COV